Caladrius Biosciences (NASDAQ: CLBS) is an American biopharmaceutical company active in the field of stem cell therapy and regenerative medicine, particularly (in 2012) of cardiovascular disease. The company was founded in 1980 and was formerly known as Corniche Group Inc, Phase III Medical Inc and NeoStem, Inc.
David J. MazzoLocation
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Caladrius Biosciences is implementing good security practices.
Read more about the latest issues in cybersecurity
Cybersecurity risk is the probability of a cyber attack or data breach on your organization. ...
NIST Special Publication 800-171, Protecting Controlled Unclassified Information in Nonfederal ...
Compare Caladrius Biosciences's security performance with other companies